Bristol Myers Squibb Co Drug Patent Portfolio

Drug Patent Number Drug Patent Title Drug Patent Expiry Status


Bristol Myers Squibb Co's Family Patents


Family Patents



Bristol Myers Squibb Co Drug List

Given below is the complete list of Bristol Myers Squibb Co's drugs and the patents protecting them.


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol Myers Squibb Co News

Bristol Myers Squibb's schizophrenia medication does not succeed in crucial trial when used alongside antipsychotic treatments.

23 Apr, 2025

Reasons Bristol Myers Squibb (BMY) is Considered a Strong Long-Term Value Investment - Yahoo Finance

22 Apr, 2025

Regulatory Agency in the United States Greenlights Bristol Myers Squibb's Schizophrenia Medication

27 Sep, 2024

FDA is set to review the approval of the first new drug for schizophrenia in more than three decades

26 Sep, 2024

See More